vs

Side-by-side financial comparison of PureCycle Technologies, Inc. (PCT) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

cbdMD, Inc. is the larger business by last-quarter revenue ($5.0M vs $2.7M, roughly 1.9× PureCycle Technologies, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -697.1%, a 691.5% gap on every dollar of revenue. cbdMD, Inc. produced more free cash flow last quarter ($-977.3K vs $-42.0M).

PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

PCT vs YCBD — Head-to-Head

Bigger by revenue
YCBD
YCBD
1.9× larger
YCBD
$5.0M
$2.7M
PCT
Higher net margin
YCBD
YCBD
691.5% more per $
YCBD
-5.6%
-697.1%
PCT
More free cash flow
YCBD
YCBD
$41.1M more FCF
YCBD
$-977.3K
$-42.0M
PCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PCT
PCT
YCBD
YCBD
Revenue
$2.7M
$5.0M
Net Profit
$-18.8M
$-283.1K
Gross Margin
59.8%
Operating Margin
-2196.1%
-5.7%
Net Margin
-697.1%
-5.6%
Revenue YoY
-1.9%
Net Profit YoY
71.0%
-1975.7%
EPS (diluted)
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCT
PCT
YCBD
YCBD
Q4 25
$2.7M
$5.0M
Q3 25
$2.4M
$4.7M
Q2 25
$1.6M
$4.6M
Q1 25
$1.6M
$4.7M
Q4 24
$0
$5.1M
Q3 24
$0
$4.6M
Q2 24
$0
$5.2M
Q1 24
$0
$4.4M
Net Profit
PCT
PCT
YCBD
YCBD
Q4 25
$-18.8M
$-283.1K
Q3 25
$-28.4M
$-680.0K
Q2 25
$-144.2M
$-895.3K
Q1 25
$8.8M
$-480.8K
Q4 24
$-64.7M
$15.1K
Q3 24
$-90.6M
$-152.8K
Q2 24
$-48.2M
$459.7K
Q1 24
$-85.6M
$-3.0M
Gross Margin
PCT
PCT
YCBD
YCBD
Q4 25
59.8%
Q3 25
58.8%
Q2 25
61.5%
Q1 25
62.3%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
PCT
PCT
YCBD
YCBD
Q4 25
-2196.1%
-5.7%
Q3 25
-1602.2%
-14.5%
Q2 25
-2763.5%
-19.6%
Q1 25
-2387.4%
-10.2%
Q4 24
-1.7%
Q3 24
-6.9%
Q2 24
-7.4%
Q1 24
-35.4%
Net Margin
PCT
PCT
YCBD
YCBD
Q4 25
-697.1%
-5.6%
Q3 25
-1167.5%
-14.4%
Q2 25
-8741.8%
-19.4%
Q1 25
559.0%
-10.1%
Q4 24
0.3%
Q3 24
-3.4%
Q2 24
8.9%
Q1 24
-68.8%
EPS (diluted)
PCT
PCT
YCBD
YCBD
Q4 25
$-0.14
Q3 25
$-0.31
Q2 25
$-0.81
Q1 25
$0.05
Q4 24
$-0.40
Q3 24
$-0.54
Q2 24
$-0.29
$-0.15
Q1 24
$-0.52
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCT
PCT
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$156.7M
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$45.9M
$9.0M
Total Assets
$922.7M
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCT
PCT
YCBD
YCBD
Q4 25
$156.7M
$3.4M
Q3 25
$234.4M
$2.3M
Q2 25
$284.1M
$1.1M
Q1 25
$22.5M
$1.8M
Q4 24
$15.7M
$2.0M
Q3 24
$83.7M
$2.5M
Q2 24
$10.9M
$2.4M
Q1 24
$25.0M
$2.1M
Stockholders' Equity
PCT
PCT
YCBD
YCBD
Q4 25
$45.9M
$9.0M
Q3 25
$68.2M
$7.2M
Q2 25
$98.9M
$6.1M
Q1 25
$238.2M
$665.8K
Q4 24
$180.4M
$1.8M
Q3 24
$241.4M
$2.0M
Q2 24
$291.6M
$3.0M
Q1 24
$336.8M
$3.1M
Total Assets
PCT
PCT
YCBD
YCBD
Q4 25
$922.7M
$11.8M
Q3 25
$989.1M
$10.4M
Q2 25
$1.0B
$9.9M
Q1 25
$787.3M
$10.9M
Q4 24
$798.4M
$11.5M
Q3 24
$788.8M
$10.6M
Q2 24
$719.8M
$13.8M
Q1 24
$734.0M
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCT
PCT
YCBD
YCBD
Operating Cash FlowLast quarter
$-28.7M
$-812.5K
Free Cash FlowOCF − Capex
$-42.0M
$-977.3K
FCF MarginFCF / Revenue
-1559.6%
-19.5%
Capex IntensityCapex / Revenue
495.1%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-183.6M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCT
PCT
YCBD
YCBD
Q4 25
$-28.7M
$-812.5K
Q3 25
$-38.5M
$-240.7K
Q2 25
$-36.7M
$-704.2K
Q1 25
$-38.9M
$-189.5K
Q4 24
$-31.8M
$-317.9K
Q3 24
$-33.4M
$167.4K
Q2 24
$-40.4M
$289.8K
Q1 24
$-39.2M
$-704.1K
Free Cash Flow
PCT
PCT
YCBD
YCBD
Q4 25
$-42.0M
$-977.3K
Q3 25
$-42.4M
$-243.6K
Q2 25
$-45.3M
$-705.7K
Q1 25
$-53.9M
$-205.0K
Q4 24
$-53.4M
$-482.3K
Q3 24
$-42.6M
$157.4K
Q2 24
$-50.8M
Q1 24
$-53.5M
$-708.7K
FCF Margin
PCT
PCT
YCBD
YCBD
Q4 25
-1559.6%
-19.5%
Q3 25
-1743.1%
-5.2%
Q2 25
-2747.1%
-15.3%
Q1 25
-3409.6%
-4.3%
Q4 24
-9.4%
Q3 24
3.5%
Q2 24
Q1 24
-16.2%
Capex Intensity
PCT
PCT
YCBD
YCBD
Q4 25
495.1%
3.3%
Q3 25
160.3%
0.1%
Q2 25
521.5%
0.0%
Q1 25
949.6%
0.3%
Q4 24
3.2%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
PCT
PCT
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
-4.40×
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCT
PCT

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons